Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Market Reports
Serialisation and data connectivity: Part II
The new wrinkle in your supply chain, <a href='https://www.manufacturingchemist.com/news/article_page/Serialisation_and_data_connectivity_Part_I/147850'>click here to read part I</a>
Serialisation and data connectivity: Part I
The new wrinkle in your supply chain
A grandmaster’s approach to successful tableting
Tableting is a fundamental unit operation in the production of pharmaceutical oral solid dosage forms. Despite its long history of use and the development of innovations such as extended dwell times, unique technologies that independently and simultaneously measure and control both tablet weight and hardness, and a weight control system that provides increased sensitivity at lower forces, production problems still occur. Here, Dr Harald Stahl, Group Director, Application and Strategy Management, GEA, provides some troubleshooting tips from an unlikely source: the chess board
Discover, learn and connect at Lab Innovations!
Experience the latest developments at the UK’s only event dedicated to the laboratory industry
Pharmacovigilance in the hands of patients
Angharad Baldwin caught up with Dr Andrew Rut, founder of MyMeds&Me, at FutureLink 2018 to talk about what software as a service means to the pharmaceutical industry and the patient ... and whether there’s such a thing as too much data
ATP detection: The balance between precision and speed
Adenosine triphosphate (ATP) is an indicator molecule for the presence of biological residues used in food production. Burcu Yordem, 3M Food Safety, explains its role in an effective hygiene monitoring programme
Making a difference in pharma contract manufacturing
With a plant near Basel, Switzerland, and a heritage of more than 40 years, contract service provider Legacy Pharmaceuticals understands the value of flexibility and experience when producing parenteral and semisolid drugs. Dr Kevin Robinson spoke to Mike Danzi, Chief Executive Officer, to find out more
Continuously driving pharmaceutical manufacturing efficiencies
Continuous manufacturing has long been accepted by a host of manufacturing industries from food and beverage to oil and gas, where it ensures the delivery of a consistent and continuous quality of product
Health experts reveal 10 most important medicines in NHS history
Antipsychotics, breast cancer drug, oral contraceptives and MMR vaccine make the top 10
Brexit trade bill: Not yet
The UK has decided it will continue to be involved with the European Medicines Agency (EMA) after Brexit. Paul Brooks, Executive Director at the Regulatory Affairs Professionals Society (RAPS) asks what does this mean for the pharmaceutical industry and patients after 2020?
Maintenance across borders
Here, Dave Friar, International Operations Director at Boulting, international engineering solutions provider, considers what you should do when preparing to hand over maintenance control on an overseas project
Treating chronic wounds with live biotherapeutics
Angharad Baldwin talks to Evelina Vågesjö, CEO, and Peter Frank, Drug Development Manager, of Swedish biologics company, Ilya Pharma, about using live bacteria to treat chronic wounds
Isolator sterility put to the test
Sterility testing must be carried out under strict aseptic conditions. Stacey Orley, Wickham Laboratories, describes the process to ensure products and devices are contaminant-free
A new way of buying and selling APIs, additives, vitamins and excipients
Swiss Kemiex and Atradius credit insurance launch unique commodity trading platform for the pharmaceutical and nutritional ingredients
The nanozyme that uses light to kill bacteria
Scientists at the RMIT University in Australia have created a nanozyme with antimicrobial properties with huge potential applications. Angharad Baldwin interviews Professor Vipul Bansal, lead researcher, to find out more
Six months and counting
With 6 months to go until the DSCSA serialisation enforcement deadline kicks in, <i>Manufacturing Chemist</i> caught up with some leading lights in the industry to find out how companies were shaping up ahead of November to mark the occasion
Invisible benefits
SCHOTT enhances its iQ platform with the introduction of the new syriQ BioPure glass syringe for sensitive drugs
Accelerating drug discovery
Angharad Baldwin of <i>Manufacturing Chemist</i> speaks to Dr Trevor Perrior, CSO of Domainex, about the development of a new GPCR drug discovery technology
The final countdown: CDMO focus areas before Feb 2019
Staffan Widengren will be presenting at <a href='https://www.tracelink.com/futurelink'>FutureLink Munich</a> on the <i>Final countdown: focus areas for a CDMO before February 2019</i>
How to boost the conversion rate of your e-commerce website in the manufacturing industry
Fifty three per cent of businesses spend less than 5% of their total marketing budget on boosting their conversion rates, and 35% of businesses have a conversion rate of less than 1%
Advances in medical technology
Overhauling operating models to create digital value
Tailor-made molecules for the drugs of tomorrow
Getting a drug to market is no easy feat, especially with tight regulations to comply with and the plethora of products that are already available. This is why a service that streamlines the discovery process and leads to improved outcomes during clinical trials for drug candidates is likely to be very desirable
PCI expands analytical laboratories at Tredegar site
Pharmaceutical outsourcing services provider PCI announces laboratory expansion at contained manufacturing centre
Standing strong
As regulatory pressure keeps rising, affecting every aspect of the drug manufacturing process, quality is an ongoing quest for pharma companies. Kevin Robinson spoke to Christina Rettig, Head of Communications at SCHOTT AG to find out more
Previous
1
2
3
4
5
6
7
8
(current)
9
Next
Trending Articles
Drug dose delivery development, manufacturing and commercialisation trends: part II
In the wake of patient-centricity in the pharmaceutical industry, drug delivery technologies have emerged as a central driver of therapeutic and patient success. Dr Kevin Robinson went online with Manuel Leal, Business Development Director, Idifarma, Steve Rode, Manager Business Development, Capsules and Health Ingredients, Lonza, and John Ross, President, Mayne Pharma US/Metrics Contract Services, to find out more
How to avoid sticking and picking in the tableting industry
John Norman and Kevin Queensen of Natoli Engineering explain
Adding more to the cell and gene therapy playbook
With notable advances in various forms of administration, including making the use of viral vectors safer, non-viral delivery with lipid nanoparticles and the growing application of electroporation, Dr Kevin Robinson (KSR) recently caught up with Jason Potter (JP), Director of Cell Biology R&D at Thermo Fisher Scientific, to learn more about how the company is helping the pharmaceutical industry to develop cell and gene therapies
How to proactively address EU HTAR implementation challenges before 2025
Data landscape challenges within the European Union (EU) have historically been driven by the different laws, processes and regulatory standards of its 27 member states (MS). As a result, drug therapeutics and health technology developers have faced the challenge of duplication of assessment efforts
Highly potent formulation development in oncology
Formulation development is a dynamic and experimental process. However, certain challenges are presented to CDMOs that add a layer of unnecessary pressure to the development process — some of which are avoidable. Louise Carpenter from PCI Pharma Services discusses
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all